SCHEMBL7870341

SCHEMBL7870341

CCCCNC(=O)c1ccc(S(=O)(=O)NC(=O)c2ccc(OC(=O)NC(=O)CN)nc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.43
EGFR P00533 3/20 0.41
CYP2C9 P11712 2/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
ALB P02768 1/20 0.40
TSHR P16473 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 1/20 0.39
P4HTM Q9NXG6 3/20 0.39
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
MEN1 O00255 1/20 0.37
MMP1 P03956 1/20 0.37
BCL2L1 Q07817 1/20 0.37
MCL1 Q07820 1/20 0.37
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7869451 0.96 CA2 (0.49) CA2EGFRALDH1A1KMT2AKDM4E
SCHEMBL7869130 0.91 KMT2A (0.44) CA2EGFRALDH1A1LMNAKMT2A
SCHEMBL7862795 0.91 EGFR (0.44) CA2EGFRP4HTMBCL2L1MCL1
SCHEMBL7867899 0.91 SMN1; SMN2 (0.43) CA2LMNAKMT2AP4HTMRAB9A
SCHEMBL7871727 0.90 CA2 (0.44) CA2EGFRALDH1A1KMT2AP4HTM
SCHEMBL7871629 0.89 CA2 (0.46) CA2EGFRALDH1A1KMT2AKDM4E
SCHEMBL7869436 0.89 NPC1 (0.44) P4HTMNPC1RAB9ABCL2L1MCL1
SCHEMBL7871605 0.88 HSP90AA1 (0.44) KMT2AP4HTMNPC1RAB9AMEN1
SCHEMBL7870554 0.86 NPC1 (0.49) CA2KMT2AP4HTMNPC1RAB9A
SCHEMBL7870566 0.86 EGFR (0.43) CA2EGFRCYP2C9ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0562512-B1 Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines HOECHST AG (DE) 2001-02-21 EP disclosed
EP-0562512-A1 Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-29 EP disclosed